Vitamin D3
fat-soluble
Key Takeaways
- FDA daily value is 20 mcg (800 IU); the Endocrine Society suggests empiric supplementation for adults 75+ and pregnant women (pmid:38828931)
- Vitamin D3 (cholecalciferol) is more effective than D2 (ergocalciferol) at raising serum 25(OH)D levels (pmid:22552031)
- Daily supplementation of 2000 IU raises 25(OH)D above 50 nmol/L in over 99% of adults with no significant safety concerns (pmid:38337676)
- Combined with 1200 mg calcium, 800 IU daily reduces hip fracture risk by approximately 31% in older adults (pmid:35842938)
- High-dose supplementation (4000-10000 IU/day) did not benefit bone density and may reduce it (pmid:31454046)
Evidence Spectrum
14 studies reviewed →Hip fracture prevention (with calcium)
A meta-analysis of 7 RCTs (n=12,620) found that daily oral supplementation of 800 IU vitamin D3 plus 1200 mg calcium reduced hip fracture risk (OR 0.69, 95% CI 0.58-0.82, p<0.0001) and non-vertebral fracture risk (OR 0.80, 95% CI 0.72-0.89, p<0.0001).8
Diabetes prevention (high-risk prediabetes)
The Endocrine Society recommends supplementation for individuals with high-risk prediabetes to potentially reduce progression to type 2 diabetes. Vitamin D influences insulin sensitivity through multiple molecular pathways including cytokine modulation and adipose tissue function.13
Respiratory infection prevention (children)
The Endocrine Society suggests supplementation for children aged 1-18 partly due to potential to lower respiratory tract infection risk. Evidence quality is considered conditional rather than strong.1
Depression prevention
The VITAL-DEP trial (n=18,353, median 5.3 years follow-up) found 2000 IU/day did not significantly reduce depression incidence or recurrence, or improve mood scores compared to placebo in adults 50+.5
PCOS symptom improvement
A prospective RCT found vitamin D3 (30,000 IU/week for 12-24 weeks) improved ovarian morphology, menstrual cycle regularity, and ovulation rates in women with PCOS, with significant testosterone reduction in a subgroup.9
14
Studies Reviewed
15 mcg
RDA (adults 19-70 years (600 IU))
100 mcg
Upper Limit
fat-soluble
Solubility
Role in the Body
Vitamin D3 (cholecalciferol) is a fat-soluble secosteroid that functions as a prohormone. It is synthesized in the skin upon UVB exposure and converted to its active form, 1,25-dihydroxyvitamin D (calcitriol), through two hydroxylations in the liver and kidneys. Calcitriol binds to the vitamin D receptor (VDR) found in nearly every tissue in the body. The primary physiological role of vitamin D is regulating calcium and phosphorus homeostasis, which is critical for bone mineralization and skeletal health. It promotes intestinal absorption of calcium and phosphorus, regulates parathyroid hormone secretion, and maintains serum calcium concentrations within a narrow range necessary for normal neuromuscular function and bone metabolism. Beyond skeletal health, vitamin D modulates immune function by influencing both innate and adaptive immunity. It affects the production of anti-inflammatory and pro-inflammatory cytokines and influences Toll-Like Receptor (TLR) expression. Research also indicates roles in insulin sensitivity, glucose metabolism, and cardiovascular health, though the clinical significance of these extraskeletal effects remains under investigation (pmid:37895163).
- Promotes intestinal calcium and phosphorus absorption
- Regulates bone mineralization and remodeling
- Modulates innate and adaptive immune responses
- Supports parathyroid hormone regulation
- Influences insulin sensitivity and glucose metabolism
- Regulates cytokine production and inflammatory pathways
Supplement Forms
Cholecalciferol (Vitamin D3)
RecommendedBioavailability: 87%
Derived from animal sources or lichen; more effective than D2 at raising serum 25(OH)D levels, especially in bolus dosing (pmid:22552031)
Ergocalciferol (Vitamin D2)
Bioavailability: 60%
Plant-derived; a meta-analysis showed D3 is significantly more efficacious than D2 at raising 25(OH)D levels (P=0.001), particularly with bolus dosing (pmid:22552031)
Calcifediol (25-hydroxyvitamin D)
Bioavailability: 95%
Pre-hydroxylated form; faster onset and more predictable serum level increases; typically reserved for malabsorption or liver disease
Food Sources
Milk, dry, nonfat (fortified)
11 mcg per 100g
Cheese, American (vitamin D fortified)
7.5 mcg per 100g
Milk, evaporated, nonfat (fortified)
2 mcg per 100g
Milk, chocolate, whole (fortified)
1.3 mcg per 100g
Milk, lowfat 1% (fortified)
1.2 mcg per 100g
Milk, nonfat/skim (fortified)
1.2 mcg per 100g
Milk, reduced fat 2% (fortified)
1.2 mcg per 100g
Milk, whole 3.25% (fortified)
0.96 mcg per 100g
Deficiency
Prevalence: Approximately 42% of US adults have serum 25(OH)D levels below 50 nmol/L (20 ng/mL); prevalence is higher in darker-skinned populations, older adults, and those at higher latitudes
Symptoms:
- Rickets in children (bone softening and deformity)
- Osteomalacia in adults (bone pain, muscle weakness)
- Increased fracture risk
- Fatigue and general malaise
- Impaired wound healing
- Bone pain and lower back pain
- Muscle weakness
Risk Factors:
- Limited sun exposure or high latitude residence
- Darker skin pigmentation
- Older age (reduced skin synthesis)
- Obesity (vitamin D sequestered in adipose tissue)
- Malabsorption disorders (celiac, Crohns, IBD)
- Exclusive breastfeeding without supplementation
- Strict vegan diet without fortified foods
- Use of sunscreen or covering clothing
Safety & Interactions
Possible Side Effects:
- • Hypercalcemia at very high doses (nausea, vomiting, weakness, frequent urination)
- • Kidney stones with excessive supplementation
- • High-dose supplementation (4000-10000 IU/day for 3 years) was associated with reduced bone mineral density at the radius compared to 400 IU/day (pmid:31454046)
Drug Interactions:
- • Corticosteroids may reduce calcium absorption and impair vitamin D metabolism
- • Orlistat and cholestyramine can reduce vitamin D absorption
- • Thiazide diuretics combined with vitamin D may cause hypercalcemia
- • Statins: vitamin D may affect statin metabolism
- • Vitamin K: synergistic effects on bone health; adequate K status recommended alongside D supplementation (pmid:39125301)
Contraindications:
- • Hypercalcemia
- • Granulomatous diseases (sarcoidosis, tuberculosis) - may cause excessive calcitriol production
- • Severe kidney disease (impaired conversion to active form; use calcitriol instead)
- • Known hypersensitivity to vitamin D3 or cholecalciferol
Frequently Asked Questions
How much Vitamin D3 should I take daily?
The FDA daily value is 800 IU (20 mcg). Adults under 70 have an RDA of 600 IU (15 mcg), while those 71+ need 800 IU (20 mcg). Research suggests 2000 IU/day is safe and effective for maintaining sufficient blood levels in most adults. Do not exceed 4000 IU/day without medical supervision.
What is the difference between Vitamin D2 and D3?
Vitamin D3 (cholecalciferol, from animal sources) is significantly more effective than D2 (ergocalciferol, from plants) at raising blood 25(OH)D levels, especially in bolus doses. D3 is generally the preferred form for supplementation.
Can Vitamin D3 prevent bone fractures?
When combined with adequate calcium intake (1200 mg/day), 800 IU of vitamin D3 daily has been shown to reduce hip fracture risk by approximately 31% in adults over 65. Vitamin D3 alone without calcium has weaker evidence for fracture prevention.
What are the signs of Vitamin D deficiency?
Common symptoms include bone pain, muscle weakness, fatigue, and increased fracture risk. Severe deficiency causes rickets in children and osteomalacia in adults. About 42% of US adults have insufficient vitamin D levels.
Is it possible to take too much Vitamin D3?
Yes. The tolerable upper limit is 4000 IU/day for adults. A 3-year clinical trial found that doses of 4000-10000 IU/day actually reduced bone mineral density compared to 400 IU/day. Excessive intake can cause hypercalcemia, nausea, and kidney stones.
Research Sources
15 peer-reviewed studies analyzed from PubMed. 9 directly cited in this review.